Wegovy
Approved for chronic weight management and for cardiovascular risk reduction in eligible adults. The most straightforward product to put in front of an insurer for weight care.
Getting a prescription
Wegovy is the semaglutide product approved specifically for chronic weight management, which makes it the one most likely to be considered by an insurer and the one whose eligibility criteria are most specific.
Its approval is written around BMI thresholds and weight-related conditions, so the evaluation is doing real work: it establishes whether you meet the criteria the label describes, not just whether a clinician is willing to prescribe.
What to know first
Wegovy has the tightest eligibility criteria of the products on this site, because its approval is specific. That makes the first two steps matter more than they do elsewhere.
The approval is written around a BMI threshold, or a lower threshold with a weight-related condition such as hypertension, type 2 diabetes, or high cholesterol. A clinician is checking whether you meet it, and that check is what a coverage request will rest on.
Contraindications include a personal or family history of medullary thyroid carcinoma or MEN 2. Cardiovascular history is worth raising, since Wegovy carries a separate indication there that can change the case for coverage.
Where a plan covers weight care, this is the product it usually names. Ask whether the clinic submits prior authorization on your behalf, because that step is where most weight-care claims are won or abandoned.
Dose escalates over roughly four to five months to a maintenance dose. Ask what the schedule is, how often you are seen, and what happens to the cost at each step.
The decision is usually Wegovy versus a cheaper compounded route, or Wegovy versus tirzepatide. They fail differently.
Approved for chronic weight management and for cardiovascular risk reduction in eligible adults. The most straightforward product to put in front of an insurer for weight care.
Same molecule, diabetes indication, different dosing. Prescribed off-label for weight and commonly refused by plans for that use. Not a substitute in coverage terms.
Not an FDA-approved generic and not reviewed as a finished product. Cheaper, and outside the approval that makes a coverage request possible at all.
For how it works, its side effects, and how it compares with the alternatives, see the semaglutide medication guide.
If a video visit suits you better than an office, the online programs prescribing it are compared on starting price at online Wegovy providers.
Wegovy is the product where coverage most often materialises, which makes the cash price and the covered price very different conversations. Only 102 of the 230 listings here publish a figure.
The largest practical factor. A clinic that submits and follows up on prior authorization changes the cost more than any discount program does.
Eligibility for these depends on insurance status and changes periodically. Ask whether the quoted price already assumes one.
Pricing is per-pen and the maintenance dose is several steps above the start. An introductory figure describes month one only.
Establish which the quoted number covers. A clinic billing a monthly membership plus pharmacy cost is quoting a different thing from an all-in program.
230 clinics we checked prescribe wegovy, spread across 31 states.
Sources: FDA Wegovy prescribing information · NIDDK, Prescription Medications to Treat Overweight & Obesity. Eligibility and prescribing decisions belong to a qualified healthcare professional. This page is informational and is not medical advice.
More on wegovy